Alabama HJR162 encourages the Alabama Medicaid Agency to assess the costs of GLP-1 medications and report findings.

Alabama HJR162 urges the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications for weight management and report its findings to the Legislature by 2027. The resolution highlights the potential benefits of these medications for managing obesity, which affects nearly 40% of adults and 15.6% of children in Alabama. The Agency is encouraged to determine potential savings and consider new drug pricing models. The resolution aims to improve health outcomes and cost savings for the state.

Alabama HJR162 encourages the Alabama Medicaid Agency to assess the costs of GLP-1 medications and report findings.

Alabama HJR162 urges the Alabama Medicaid Agency to evaluate the overall costs of GLP-1 medications for weight management and report its findings to the Legislature by 2027. The resolution highlights the potential benefits of these medications for managing obesity, which affects nearly 40% of adults and 15.6% of children in Alabama. The Agency is encouraged to determine potential savings and consider new drug pricing models. The resolution aims to improve health outcomes and cost savings for the state.